Acute Pancreatitis: Why Surviving the Attack Isn't Enough, and What Actually Prevents the Next One

24 September 2026
MIT
Acute Pancreatitis: Why Surviving the Attack Isn't Enough, and What Actually Prevents the Next One

Acute pancreatitis is a sudden inflammation of a small gland tucked behind the stomach, and it begins when digestive enzymes switch on inside the gland instead of inside the intestine. In most cases the attack settles within a few days of hospital treatment — and that is exactly where the real problem starts: the attack ends, but whatever caused it is still there. Which means the important question after discharge is not "are you better?" but "what caused this, and what did we do about it?"


This article explains how acute pancreatitis is diagnosed, what causes it most often worldwide and in Saudi Arabia, how likely it is to come back, and which steps have actually been shown to reduce the odds of a second attack. It is educational and does not replace medical care — and it is not a way to work out what is causing abdominal pain you are having right now.


What is the pancreas, and why does inflaming it hurt like that?


The pancreas is a flat gland about 15 cm long, sitting behind the stomach. It has two jobs: releasing enzymes that digest fat, protein and starch in the small intestine, and releasing hormones into the blood — insulin being the famous one.


Those enzymes are made in an inactive form and are meant to be switched on only after they reach the intestine. Mayo Clinic describes what happens when that sequence breaks down in plain words: "If the enzymes are turned on too soon, they can start acting like digestive juices inside the pancreas. This action can irritate, damage or destroy cells." In other words, the gland starts digesting itself. That is why the pain arrives so suddenly and so hard, and why acute pancreatitis is assessed in hospital rather than managed at home.


The pain has a recognisable signature


The textbook description is "epigastric discomfort that often radiates to the back." Mayo Clinic adds that it may feel worse after eating and can come with nausea, vomiting, fever, a fast heartbeat, bloating and tenderness when the belly is touched.


Two practical points follow:


  • Because it spreads to the back, many people file it under "muscle strain" or "my spine again" — and wait.
  • Pain that worsens after a meal, especially a rich one, is a common clue, because eating asks an inflamed gland to go to work.


How it is diagnosed: the two-out-of-three rule


Under the revised Atlanta classification, the diagnosis needs at least two of three elements, as summarised by StatPearls:


  • Characteristic abdominal pain — "epigastric discomfort that often radiates to the back."
  • A serum amylase or lipase level "3 or more times the upper limit of normal."
  • Imaging findings consistent with acute pancreatitis on ultrasound, CT or MRI.


So one blood test neither confirms nor excludes it on its own — and, equally, typical pain plus a lipase three times the upper limit is enough to diagnose without rushing to a CT scan. The 2024 American College of Gastroenterology (ACG) guideline advises an ultrasound for every patient, reserving CT for "uncertain diagnosis or failure to improve in 48-72 hours."


The enzyme number does not tell you how severe it is


This is one of the most commonly misread points. A lipase ten times the upper limit is not necessarily worse than one four times the limit. The Atlanta classification grades severity by organ failure, how long it lasts, and local complications — not by how high the enzyme went:


  • Mild: no organ failure and no local or systemic complications.
  • Moderately severe: transient organ failure (under 48 hours) or local complications.
  • Severe: persistent organ failure (over 48 hours), often across several organ systems.


Most cases land in the first box. That is good news — and it is also the source of the problem the rest of this article is about: when an attack passes uneventfully, it is easy to file it away as an accident that is over.


The cause is where the real story starts


Acute pancreatitis is not one disease with one cause. It is a common endpoint reached by several different routes, and working out which route your body took decides everything that follows.


The global picture


StatPearls gives this distribution: gallstones and biliary sludge 35-40%, chronic alcohol use 17-25%, then hypertriglyceridemia, medications, procedures such as ERCP, trauma, and genetic and metabolic causes. Between 10% and 20% remain idiopathic — no cause found despite appropriate evaluation.


The Saudi picture: the numbers vary wildly, the direction does not


A Saudi systematic review (Alharbi, Cureus 2023; 10 studies, 1,695 participants, predominantly from the Riyadh region) pulled together what has been published locally. The headline is that biliary (gallstone) and idiopathic causes are the most frequent — but the percentages swing enormously between studies: biliary causes ranged from 15.6% to 81%, idiopathic from 4% to 76.8%, while other causes stayed far lower — alcohol 1.8-11.2%, hyperlipidemia 1-8%, drug-related 2-5%.


That spread is wide enough to deserve honesty: nobody can tell you the exact share of gallstone-related pancreatitis in Saudi Arabia. The review itself lists among its limitations the "lack of relevant published papers in many other regions" and coverage of only three regions. What can be said with less ambition and more use: in the Saudi setting, the first suspect is the gallbladder, not the food. Average reported mortality across the studies that reported it was 2.2%.


Why surviving the attack isn't enough


Here is the spine of the matter. A Dutch study (Clinical Gastroenterology and Hepatology, 2016) followed 669 patients after a first episode of acute pancreatitis across 15 hospitals, with a median follow-up of 57 months:


  • 17% had recurrent pancreatitis.
  • 7.6% progressed to chronic pancreatitis.
  • The split by cause was stark: biliary 12% recurrent and 3% chronic, versus alcoholic 24% and 16%, and idiopathic/other 25% and 10%.


And the study's sharpest finding has nothing to do with food at all: smoking. The cumulative five-year risk of recurrence was 40% in smokers versus 13% in non-smokers, and the cumulative risk of chronic pancreatitis reached 30% where alcohol misuse and smoking were combined. The authors concluded that "smoking is the predominant risk factor for recurrent disease."


Read those numbers slowly. Roughly one in six comes back. And the difference between the people who come back and the people who don't is usually not luck — it is something identifiable and treatable: a stone that was never removed, a triglyceride level that was never brought down, a cigarette that was never given up.


So what actually prevents the next attack?


If the cause was gallstones, the operating date is the treatment


This is the clearest item in the whole file. In the randomised multicentre PONCHO trial (The Lancet, 2015), 266 patients with mild gallstone pancreatitis were assigned either to gallbladder removal during the same hospital admission or to an interval operation 25-30 days after discharge. Within six months, recurrent gallstone-related complications or death occurred in 23 (17%) of 136 patients in the interval group versus 6 (5%) of 128 in the same-admission group — risk ratio 0.28 (95% CI 0.12-0.66; p=0.002).


Accordingly, the 2024 ACG guideline states that cholecystectomy should be done "preferably before discharge in mild acute biliary pancreatitis."


Notice the tension with something we published earlier. In our article on advice that quietly got reversed we argued that guidance changes and old rules linger; here the change runs the other way. We have also written that most silent gallstones do not need surgery — and that remains true. Gallstone pancreatitis is the exception that flips the rule: the moment a stone causes an attack of pancreatitis it is no longer silent, and postponing the operation becomes a decision with a published number attached — 17% versus 5%.


If the cause was triglycerides


This is the one cause you can see coming on an ordinary lipid panel before anything happens. The Endocrine Society clinical practice guideline (2012) classifies fasting triglycerides as:


  • Normal: under 150 mg/dl.
  • Mild hypertriglyceridemia: 150-199.
  • Moderate: 200-999.
  • Severe: 1000-1999.
  • Very severe: 2000 or above.


The guideline states plainly that "the risk of pancreatitis markedly increases with very severe triglyceride levels above 2000 mg/dl, but it can be prevented by maintaining triglyceride levels below 1000 mg/dl." For this group it recommends "combining reduction of dietary fat and simple carbohydrate intake with drug treatment," adding that "a fibrate should be used as a first-line agent."


Note the order carefully: the medication is not a cosmetic extra here, and diet is part of the plan rather than a substitute for it.


If no cause is found


"Idiopathic" is not a final diagnosis so much as an unfinished search — and it carries the highest recurrence rate in the Dutch cohort (25%). For these cases the 2024 ACG guideline suggests considering "repeat ultrasound, MRI, and/or endoscopic ultrasound," and recommends cholecystectomy after a second episode with no identified cause.


Smoking: the least-discussed factor and the most modifiable


Mayo Clinic lists cigarette smoking among the risk factors and describes it as tripling the risk, and you have already seen what it does to recurrence — 40% versus 13% at five years. If you have just come out of an attack, this is the strongest single decision available to you today, and the one with the largest effect on the next five years.


What changed inside the hospital: less fluid, earlier food


Two widely repeated beliefs about treating an attack are now out of date.


First, flooding the patient with IV fluids. In the WATERFALL trial (New England Journal of Medicine, 2022), 249 patients were randomised to aggressive or moderate fluid resuscitation. The primary outcome did not improve — development of moderately severe or severe pancreatitis was 22.1% versus 17.3% (adjusted relative risk 1.30; 95% CI 0.78-2.18; p=0.32) — while fluid overload rose to 20.5% versus 6.3% (adjusted relative risk 2.85; 1.36-5.94; p=0.004). The safety monitoring board halted the trial early "owing to significantly worse results with respect to safety outcomes, and the lack of trend toward improved outcomes." ACG now advises that "moderately aggressive hydration is most important the first 6-12 hours" and is "of little benefit after 24-48 hours."


Second, prolonged fasting. For mild disease the 2024 ACG guideline recommends "early oral feeding with low fat solid diet (within 24-48 hours) as tolerated," and to "avoid parenteral nutrition if possible."


In fairness to the reader: both of these are decisions your medical team makes, not you. They are here for one reason — if a relative tells you the treatment is a week of fasting and bags of fluid, the evidence has moved.


A question that keeps coming up: do GLP-1 weight-loss drugs cause pancreatitis?


A 2025 review in the Cleveland Clinic Journal of Medicine addressed exactly this. Its summary: the FDA label warns that "acute pancreatitis has been observed" but does not contraindicate use in people with a prior history, and "recent large meta-analyses do not support a class-wide risk." In the LEADER trial the incidence was 0.4% versus 0.5%; in SCALE it was 0.4% versus under 0.1%; and a network meta-analysis of 102,257 participants found a neutral relationship (relative ratio 0.96).


In a Cleveland Clinic cohort of 161 patients with prior pancreatitis who started these drugs, 10% had a recurrence — with "more than half of the episodes… attributable to causes other than GLP-1 receptor agonist therapy." The authors' position is that clinicians "should not limit the use of GLP-1 receptor agonists… because of a history of pancreatitis," but should counsel patients and monitor closely.


That does not close the question, and it is not a decision to make alone. We covered these medicines at length in what they actually do and what happens when you stop, and the same rule applies: this is a conversation with your doctor, who knows your full history.


The real Saudi gap: we blame the food and overlook the stones


Hold the evidence above against what the public actually believes. In a study from Tabuk (Cureus 2023, 549 participants), 64.1% had never received any information about pancreatitis and its risk factors, 58.3% answered "I don't know" when asked about symptoms, and only 55.6% said they would be very likely to seek medical help if symptoms appeared.


In a study from the Eastern Province (Cureus 2024, 446 participants), overall knowledge scored 46%, and 50.9% recognised abdominal pain as a symptom. But here is the detail that matters most: 62.6% knew that a high-fat diet is a risk factor, while only 32.1% knew that gallstones are.


The two surveys disagree about the numbers and agree about the direction — and together they expose a striking mismatch: the best-known cause is not the leading one, and the leading cause in Saudi series is the least well known. People blame food roughly twice as often as they blame the gallbladder, while the evidence points close to the opposite way. Which is why the most useful thing after an attack is not a list of forbidden foods, but one question for your doctor: "Did I have an ultrasound of my gallbladder, and what did it show?"


When to seek help immediately


Acute pancreatitis is assessed in hospital. Seek medical care if any of the following appears, and do not try to wait until morning:


  • Severe, sudden pain in the upper abdomen, particularly if it spreads to the back or worsens after eating.
  • Pain so bad you cannot find a comfortable position — Mayo Clinic's advice here is to "seek immediate medical help."
  • Persistent vomiting that stops you keeping fluids down.
  • Fever, a racing pulse, yellowing of the eyes or skin, or dark urine.
  • Sudden abdominal pain that does not improve, even if it is bearable.


Pay closer attention if you have known gallstones, high triglycerides, a previous attack, or have recently had an ERCP. This article is educational; every medical decision — including any change to a medication or a diet — belongs with your doctor.


Where Bakery 8 stands on this


Let us say it plainly: no bread — not ours, not anyone's — prevents or treats pancreatitis. This is a condition whose plan is set in a hospital and a clinic, and the things that most reliably stop it coming back are not sold on a shelf: a date for gallbladder surgery, a drug that lowers triglycerides, and giving up cigarettes.


Honesty requires going further than that. The higher-fat eating pattern our products serve is not automatically the right pattern for someone recovering from an attack of pancreatitis. NIDDK advises people with pancreatitis to "eat a low-fat diet," and ACG recommends a low-fat solid diet in early recovery. Anyone in that position needs their doctor and their dietitian — not a category of baked goods. We say so even though it does not help us.


What remains true, and small, and inside its limits: cutting simple carbohydrates is a recognised part of the Endocrine Society's own plan for high triglycerides — alongside reducing dietary fat and taking the medication, not instead of them. So if your doctor is tracking your triglyceride number with you, swapping a high-sugar bread or dessert for a sugar-free option or keto granola with numbers you can read may make the dietary part easier to stick to. That is the entire claim — and nothing beyond it.


Frequently asked questions


Does acute pancreatitis heal completely?


In most cases, yes. NIDDK describes acute pancreatitis as "short term and may go away in a few days with treatment." But recovering from the attack and preventing the next one are two different things: 17% of patients in the Dutch cohort had a recurrence, and 7.6% progressed to chronic pancreatitis over follow-up.


Did a fatty meal cause my attack?


Usually not directly. The commonest causes are gallstones (35-40% worldwide) and alcohol, then severe hypertriglyceridemia. A rich meal can bring symptoms on or make them worse, but the structural cause is usually in the gallbladder, the triglycerides, or a medication.


Does a very high lipase mean my case is severe?


No. Diagnosis requires at least a three-fold rise above the upper limit of normal, but the size of the rise does not grade severity. Severity is classified by organ failure, its duration, and local complications — not by the number on the report.


Should I have my gallbladder removed after a single attack?


If the cause was biliary and the attack was mild, the evidence and the guidelines lean strongly towards yes — preferably before you leave hospital. PONCHO showed 5% recurrent complications with same-admission surgery versus 17% with an interval operation. The decision belongs with your surgeon, because it depends on your cause, the severity of your attack, and your overall health.


I was taking a weight-loss injection and developed severe abdominal pain. What should I do?


Get an urgent medical assessment regardless of the medication; sudden severe abdominal pain needs examining, not self-interpreting. And do not stop any prescribed medicine on the strength of an article — speak to your doctor, since the large reviews have not supported a class-wide risk.


The bottom line


Acute pancreatitis is diagnosed on two of three: characteristic pain, an enzyme three times the upper limit, and imaging — and the enzyme number does not measure severity. Most attacks pass, but roughly one in six comes back, and smoking is the single biggest factor in whether it does. The clearest ways to prevent a second attack are not diets: they are removing the gallbladder at the right time if stones were the cause, controlling triglycerides if they were, and searching seriously for the cause when it looks "idiopathic."


So if you have come through an attack, come away with at least one answer: why did it happen?


At Bakery 8 in Riyadh, Saudi Arabia, we are not part of treating this illness — but we think knowing your number and your cause is worth saying out loud, even when it sells nothing. Browse our products if they fit the plan your doctor has set, never in place of it.


References


  1. Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. American Journal of Gastroenterology. 2024;119(3):419-437. doi:10.14309/ajg.0000000000002645
  2. Wang CF, Tariq A, Chandra S. Acute Pancreatitis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2 August 2025.
  3. da Costa DW, Bouwense SA, Schepers NJ, et al. Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial. The Lancet. 2015;386(10000):1261-1268.
  4. de-Madaria E, Buxbaum JL, Maisonneuve P, et al. Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis (WATERFALL). New England Journal of Medicine. 2022;387(11):989-1000.
  5. Ali UA, Issa Y, Hagenaars JC, et al. Risk of Recurrent Pancreatitis and Progression to Chronic Pancreatitis After a First Episode of Acute Pancreatitis. Clinical Gastroenterology and Hepatology. 2016;14(5):738-746.
  6. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2012;97(9):2969-2989. doi:10.1210/jc.2011-3213
  7. Mehta AE, Lomeli LD, Pantalone KM. Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce. Cleveland Clinic Journal of Medicine. 2025;92(8):483-489. doi:10.3949/ccjm.92a.24113
  8. Alharbi MS. The Etiology and Epidemiological Features of Acute Pancreatitis in Saudi Arabia: A Systematic Review. Cureus. 2023;15(10):e46511. doi:10.7759/cureus.46511
  9. Alalawi Y, Daghreeri AA, Alkhudairy AI, et al. Pancreatitis Prevention in Tabuk City, Kingdom of Saudi Arabia: Evaluating Public Knowledge and Raising Awareness of Risk Factors and Symptoms. Cureus. 2023;15(10):e47069. doi:10.7759/cureus.47069
  10. Alnami LK, Alghannam F, Alalaiwi AA, et al. An Assessment of Public Awareness Regarding Pancreatitis: A Cross-Sectional Study in the Eastern Province of Saudi Arabia. Cureus. 2024;16(10):e71483. doi:10.7759/cureus.71483
  11. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pancreatitis. niddk.nih.gov.
  12. Mayo Clinic. Pancreatitis — Symptoms and causes. mayoclinic.org.


Related keywords: acute pancreatitis, pancreatitis symptoms, pancreatitis causes, gallstone pancreatitis, lipase test, triglycerides and pancreatitis, chronic pancreatitis, cholecystectomy after pancreatitis, upper abdominal pain radiating to the back, pancreatitis in Saudi Arabia.